Improving access and adherence for overactive bladder treatment
Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions
This study is testing a new tool to help women with overactive bladder get better access to treatment and stick with it, so they can feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Redwood City, California) |
| Trial ID | NCT06094543 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the treatment access and adherence for individuals suffering from overactive bladder (OAB) and urinary incontinence (UI), conditions that affect millions of Americans. It will utilize a patient engagement tool designed to address barriers to treatment, such as cost and tolerability, and to improve overall quality of life. The study focuses on female patients aged 18 and older who have experienced OAB symptoms for at least three months and have not previously undergone behavioral treatment. By identifying and supporting vulnerable populations, the study seeks to increase therapy utilization and adherence among those most in need.
Who should consider this trial
Good fit: Ideal candidates for this study are females aged 18 years or older who have experienced OAB symptoms for at least three months and have not previously received behavioral treatment.
Not a fit: Patients with certain comorbid conditions, such as interstitial cystitis or neurological disorders, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve treatment adherence and quality of life for patients with overactive bladder and urinary incontinence.
How similar studies have performed: Other studies have shown success in improving treatment adherence for chronic conditions through patient engagement strategies, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female aged 18 years or older * OAB symptoms for at least 3 months * English/Spanish language skills and cognitive status sufficient to complete all study related materials * Behavioral treatment naïve patients * Previously treated OAB patients without supervised pelvic floor physical therapy or pharmacotherapy within 1 year Exclusion Criteria: * Post void residual urine \> 150ml * Confirmed diagnosis of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) * Pregnant or breastfeeding patients * Patients residing in a nursing home * Comorbid neurological conditions, including spinal cord injury, progressive neurologic illnesses (e.g. Multiple Sclerosis, Parkinson's disease) or central nervous system disease (e.g. brain tumor, stroke) * Stage 2 or greater pelvic organ prolapse * Any history of urethral stricture * Any history of pelvic irradiation * Any history of bladder malignancy * Current symptomatic urinary tract infection (UTI), unresolved by the time of enrollment * Hematuria without a clinical evaluation * History or current use of indwelling urinary foley catheterization, suprapubic tube or intermittent catheterization * Patients with UI treated with onabotulinumtoxinA, sacral neuromodulation, or percutaneous tibial nerve stimulation (third line therapies)
Where this trial is running
Redwood City, California
- Stanford Pelvic Health Center — Redwood City, California, United States (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.